BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 19, 2026
Home » Authors » Brady Huggett

Articles by Brady Huggett

Angry Merck Jurors Point To Public's Distaste For Pharma

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Ambit's $31M Series C Due To 'Tremendous' Technology

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Want To Make A Deal? Make Sure Potential Suitors Know Of Interest

Nov. 1, 2011
By Brady Huggett
VANCOUVER - Dating advice often counsels that the best way to get a date is to ask for one. The same could be said for biotechnology companies seeking pharmaceutical partnerships. It's possible that big pharma will get wind of a young company's science, approach and begin the partnering dance, but making the first move for biotechnology companies and being proactive can't hurt. (BioWorld Today)
Read More

Awaiting Aldurazyme Approval, BioMarin Files For Public Offering

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Religious Leaders Grab Horns Of Industry's Ethical Dilemmas

Nov. 1, 2011
By Brady Huggett
No Abstract
Read More

Panacos' Stock Tumbles On Pushback Of HIV Phase III

Dec. 21, 2006
By Brady Huggett

Panacos' Stock Tumbles On Pushback Of HIV Phase III

Dec. 21, 2006
By Brady Huggett

OncoGenex Files For $48M IPO, Seeks Listings On Nasdaq, TSX

Dec. 14, 2006
By Jennifer Boggs and Brady Huggett

Previous Success Indicators Prove Shaky; Markets Wary

Nov. 13, 2006
By Brady Huggett

Previous Success Indicators Prove Shaky; Markets Wary

Nov. 13, 2006
By Brady Huggett
Previous 1 2 3 4 5 6 7 8 9 … 74 75 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2026.
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • Elderly hands holding broken brain structure

    Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

    BioWorld Science
    Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
  • ALN-5288 lowers tau levels in preclinical models

    BioWorld Science
    Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
  • International currency symbols

    Capital remains selective in ‘barbell’ biotech market

    BioWorld
    Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing